In people who have type II diabetes, GLP1 agonists (GLP1a) improves their sensitivity to insulin (a hormone that lowers blood glucose), reduces the secretion of glucagon (a hormone that increases blood glucose) and it slows gastric emptying
Over 68 weeks, semaglutide 2.4 mg produced 14.9% mean body weight reduction versus 2.4% with placebo
Phase Early escalation Weeks 5-8 Weekly Dose 4 mg Notes Increase by 2 mg every 4 weeks
Once injected, it binds to GHRH receptors on the pituitary gland and triggers the release of growth hormone in natural, pulsatile waves (the same rhythmic pattern your body produced during younger years)
This dual actionweight reduction plus improved metabolic markerscan reduce the burden on an already-stressed immune system
Migraine pain comes from irritated membranes and blood vessels The migraine attack leads to a release of inflammatory substances in the brain near the arteries and the membrane (the meninges) that surrounds your brain